Influence of glucocorticoids and growth hormone on insulin sensitivity in humans (Q38091130)

28 August 2017

title

Influence of glucocorticoids and growth hormone on insulin sensitivity in humans (English)

1 reference

28 August 2017

K C J Yuen

1 reference

28 August 2017

L E Chong

series ordinal

1 reference

28 August 2017

M C Riddle

series ordinal

1 reference

28 August 2017

publication date

1 June 2013

1 reference

28 August 2017

1 reference

28 August 2017

1 reference

28 August 2017

1 reference

28 August 2017

page(s)

651-663

1 reference

Insulin resistance: definition and consequences

28 August 2017

cites work

1 reference

21 January 2018

1 reference

Immunoassay of endogenous plasma insulin in man

21 January 2018

1 reference

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

The role of incretins in glucose homeostasis and diabetes treatment

21 January 2018

1 reference

Loss of early insulin secretion leads to postprandial hyperglycaemia

21 January 2018

1 reference

Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss

21 January 2018

1 reference

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

Correlation between serum resistin level and adiposity in obese individuals

21 January 2018

1 reference

Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians

21 January 2018

1 reference

Use of oral corticosteroids in the United Kingdom

21 January 2018

1 reference

Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients

21 January 2018

1 reference

11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response

21 January 2018

1 reference

Glucocorticoids and insulin resistance: old hormones, new targets

21 January 2018

1 reference

Adrenalectomy increases sensitivity to central insulin.

21 January 2018

1 reference

Twenty-four-hour profiles of plasma glucose, insulin, C-peptide and free fatty acid in subjects with varying degrees of glucose tolerance following short-term, medium-dose prednisone (20 mg/day) treatment: evidence for differing effects on insulin s

21 January 2018

1 reference

Intracellular skeletal muscle glucose metabolism is differentially altered by dexamethasone treatment of normoglycemic relatives of type 2 diabetic patients.

21 January 2018

1 reference

Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.

21 January 2018

1 reference

11beta-hydroxysteroid dehydrogenase type 1 and obesity

21 January 2018

1 reference

Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans.

21 January 2018

1 reference

Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy men.

21 January 2018

1 reference

Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients.

21 January 2018

1 reference

Insulin resistant subjects lack islet adaptation to short-term dexamethasone-induced reduction in insulin sensitivity

21 January 2018

1 reference

The diabetogenic effects of glucocorticoids are more pronounced in low- than in high-insulin responders

21 January 2018

1 reference

Changes in insulin secretion and glucose metabolism induced by dexamethasone in lean and obese females

21 January 2018

1 reference

Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects

21 January 2018

1 reference

Influence of Glucocorticoids on Glucagon Secretion and Plasma Amino Acid Concentrations in Man

21 January 2018

1 reference

Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.

21 January 2018

1 reference

Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes

21 January 2018

1 reference

Effect of growth hormone on carbohydrate and lipid metabolism

21 January 2018

1 reference

Insulin and GH signaling in human skeletal muscle in vivo following exogenous GH exposure: impact of an oral glucose load

21 January 2018

1 reference

Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes

21 January 2018

1 reference

Evidence for increased sensitivity of fuel mobilization to growth hormone during short-term fasting in humans

21 January 2018

1 reference

The metabolic role of growth hormone in humans with particular reference to fasting

21 January 2018

1 reference

Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy

21 January 2018

1 reference

Clinical pharmacological aspects of growth hormone administration

21 January 2018

1 reference

Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults

21 January 2018

1 reference

Diurnal patterns of triglycerides, free fatty acids, blood sugar, and insulin during carbohydrate-induction in man and their modification by nocturnal suppression of lipolysis

21 January 2018

1 reference

Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: effects of insulin sensitization therapy

21 January 2018

1 reference

Free fatty acid kinetics in the late phase of postexercise recovery: importance of resting fatty acid metabolism and exercise-induced energy deficit.

21 January 2018

1 reference

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

21 January 2018

1 reference

Cellular mechanisms of insulin resistance

21 January 2018

1 reference

Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover

21 January 2018

1 reference

Glucocorticoid induction of epinephrine synthesizing enzyme in rat skeletal muscle and insulin resistance

21 January 2018

1 reference

Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man.

21 January 2018

1 reference

Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome

21 January 2018

1 reference

Circadian Cortisol Secretory Rhythms in Cushing's Disease*

21 January 2018

1 reference

The study of spontaneous GH secretion after 36-h fasting distinguishes between GH-deficient and normal adults

21 January 2018

1 reference

The human glucocorticoid receptor: one gene, multiple proteins and diverse responses

21 January 2018

1 reference

The effects of glucocorticoids on adipose tissue lipid metabolism

21 January 2018

1 reference

Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?

21 January 2018

1 reference

Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects

21 January 2018

1 reference

The dawn phenomenon, an early morning glucose rise: implications for diabetic intraday blood glucose variation

21 January 2018

1 reference

Daily profiles of salivary and urinary melatonin and steroids in healthy prepubertal boys.

21 January 2018

1 reference

Failure of cortisol blockade to inhibit early morning increases in basal insulin requirements in fasting insulin-dependent diabetics

21 January 2018

1 reference

Abnormal pulsatile secretion of growth hormone in non‐insulin‐dependent diabetes mellitus

21 January 2018

1 reference

Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM.

21 January 2018

1 reference

Growth hormone (GH) response to GH-releasing peptide-6 and GH-releasing hormone in normal-weight and overweight patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

Frequency of the dawn phenomenon in type 2 diabetes: implications for diabetes therapy

21 January 2018

1 reference

Improved tolerance to sequential glucose loading (Staub-Traugott effect): size and mechanisms

21 January 2018

1 reference

Absence of facilitated glucose disposal (Staub-Traugott effect) in subjects with hypopituitarism

21 January 2018

1 reference

Preservation of glucose tolerance and insulin secretory response to repeated glucose levels by the feeding of minimal glucose during prolonged fasting

21 January 2018

1 reference

Improved tolerance to successive glucose loads in acromegaly

21 January 2018

1 reference

Mechanisms involved in the side effects of glucocorticoids

21 January 2018

1 reference

Diabetes in Cushing syndrome: basic and clinical aspects

21 January 2018

1 reference

Pathophysiology of Diabetes Mellitus in Cushing’s Syndrome

21 January 2018

1 reference

Adipocyte-derived hormones, cytokines, and mediators

21 January 2018

1 reference

Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome

21 January 2018

1 reference

Nocturnal hypoglycemia identified by a continuous glucose monitoring system in patients with primary adrenal insufficiency (Addison's Disease).

21 January 2018

1 reference

Insulin action in human adipose tissue in acromegaly

21 January 2018

1 reference

Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control

21 January 2018

1 reference

Pegvisomant improves insulin sensitivity and reduces overnight free fatty acid concentrations in patients with acromegaly.

21 January 2018

1 reference

Glucose homeostasis in acromegaly: effects of long-acting somatostatin analogues treatment.

21 January 2018

1 reference

Effects of two different somatostatin analogs on glucose tolerance in acromegaly

21 January 2018

1 reference

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency

21 January 2018

1 reference

Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity

21 January 2018

1 reference

Growth hormone and glucose homeostasis

21 January 2018

1 reference

Glucose and fat metabolism in adults with growth hormone deficiency

21 January 2018

1 reference

Changes in free rather than total insulin-like growth factor-I enhance insulin sensitivity and suppress endogenous peak growth hormone (GH) release following short-term low-dose GH administration in young healthy adults

21 January 2018

1 reference

Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency

21 January 2018

1 reference

Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults

21 January 2018

1 reference

Effects of Cortisol on Carbohydrate, Lipid, and Protein Metabolism: Studies of Acute Cortisol Withdrawal in Adrenocortical Failure

21 January 2018

1 reference

Non-insulin-dependent diabetic patients (NIDDMs) do not demonstrate the dawn phenomenon at presentation

21 January 2018

1 reference

The frequency and amplitude of growth hormone secretory episodes as determined by deconvolution analysis are increased in adolescents with insulin dependent diabetes mellitus and are unaffected by short-term euglycaemia

21 January 2018

1 reference

Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with Type 1 (insulin-dependent) diabetes mellitus

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DME.12184

1 reference

28 August 2017

1 reference